Clinical Trial Update: Leucovorin for the Treatment of Language Impairment in Children With Autism Spectrum Disorder [Phase 2]

View source ↗

Summary

Phase 2 trial update for leucovorin in treating language impairment in children with Autism Spectrum Disorder; the study is currently ACTIVE_NOT_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• Leucovorin (folinic acid)

Snippet

Sponsor: Southwest Autism Research & Resource Center | Conditions: Autism Spectrum Disorder | Phase 2 | Status: ACTIVE_NOT_RECRUITING